Efficacy of Chinese herbal medicine on health-related quality of life (SF-36) in hypertensive patients: A systematic review and meta-analysis of randomized controlled trials

Complementary Therapies in Medicine

Volumn 23, Issue 3, 2015, Pages 494-504

  Jiao, Hua Chen ^a   Ju, Jian Qing ^b   Li, Yun Lun ^a,b   Ma, Xue Sheng ^c   Jiang, Hai Qiang ^b   Zhao, Jing ^b   Shen, Zhen Zhen ^b   Yang, Wen Qing ^b  

^a AFFILIATED HOSPITAL OF SHANDONG UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b SHANDONG UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c UNIVERSITY OF THE WESTERN CAPE   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL; HERBACEOUS AGENT; NIMODIPINE;

ARTICLE; CHINA; CHINESE MEDICINE; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; DRUG RESPONSE; EMOTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MENTAL HEALTH; META ANALYSIS (TOPIC); PHYSICAL PERFORMANCE; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SHORT FORM 36; SOCIAL STATUS; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; META ANALYSIS; PSYCHOLOGY;

DRUGS, CHINESE HERBAL; HUMANS; HYPERTENSION; QUALITY OF LIFE; SURVEYS AND QUESTIONNAIRES;

EID: 84937628101     PISSN: 09652299     EISSN: 18736963     Source Type: Journal    
DOI: 10.1016/j.ctim.2015.04.002     Document Type: Article

References (44)

1. Weber M.A., Schiffrin E.L., White W.B., Mann S., Lindholm L.H., Kenerson J.G., Flack J.M., Carter B.L., Materson B.J., Ram C.V., et al. Clinical practice guidelines for the management of hypertension in the community a statement by the american society of hypertension and the international society of hypertension. J. Hypertens. 2014, 32(1):3-15.
2. Trevisol D.J., Moreira L.B., Kerkhoff A., Fuchs S.C., Fuchs F.D. Health-related quality of life and hypertension: a systematic review and meta-analysis of observational studies. J. Hypertens. 2011, 29(2):179-188.
3. Wang R., Zhao Y., He X., Ma X., Yan X., Sun Y., Liu W., Gu Z., Zhao J., He J. Impact of hypertension on health-related quality of life in a population-based study in Shanghai, China. Public Health 2009, 123(8):534-539.
4. Li W., Liu L., Puente J.G., Li Y., Jiang X., Jin S., Ma H., Kong L., Ma L., He X., et al. Hypertension and health-related quality of life: an epidemiological study in patients attending hospital clinics in China. J. Hypertens. 2005, 23(9):1667-1676.
5. de Souza W.A., Yugar-Toledo J.C., Bergsten-Mendes G., Sabha M., Moreno H. Effect of pharmaceutical care on blood pressure control and health-related quality of life in patients with resistant hypertension. Am. J. Health Syst. Pharm.: AJHP 2007, 64(18):1955-1961. (Official Journal of the American Society of Health-System Pharmacists).
6. Hermans M.P., De Coster O., Seidel L., Albert A., Van de Borne P. Quality of life and efficacy of nebivolol in an open-label study in hypertensive patients. The QoLaN study. Blood Press. Suppl. 2009, 1:5-14.
7. Okano Y., Tamura K., Masuda S., Ozawa M., Tochikubo O., Umemura S. Effects of angiotensin II receptor blockers on the relationships between ambulatory blood pressure and anti-hypertensive effects, autonomic function, and health-related quality of life. Clin. Exp. Hypertens. (New York, NY: 1993) 2009, 31(8):680-689.
8. Raskeliene V., Babarskiene M.R., Macijauskiene J., Seskevicius A. Impact of duration and treatment of arterial hypertension on health-related quality of life. Medicina (Kaunas, Lithuania) 2009, 45(5):405-411.
9. Trevisol D.J., Moreira L.B., Fuchs F.D., Fuchs S.C. Health-related quality of life is worse in individuals with hypertension under drug treatment: results of population-based study. J. Hum. Hypertens. 2012, 26(6):374-380.
10. Wolff M., Sundquist K., Larsson Lonn S., Midlov P. Impact of yoga on blood pressure and quality of life in patients with hypertension-a controlled trial in primary care, matched for systolic blood pressure. BMC Cardiovasc. Disord. 2013, 13(1):111.
11. Cuevas Fernandez F.J., Marco Garcia M.T., Rodriguez Alvarez C., Iglesias Giron M.J., Aguirre-Jaime A. Is there an association between physical exercise and the quality of life of hypertensive patients?. Scand. J. Med. Sci. Sports 2007, 17(4):348-355.
12. Maruf F.A., Akinpelu A.O., Salako B.L. Self-reported quality of life before and after aerobic exercise training in individuals with hypertension: a randomised-controlled trial. Appl. Psychol. Health Well Being 2013, 5(2):209-224.
13. Lu X.Y., Shi Z.X. Key points in treating hypertension by integrative medicine. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chin. J. Integr. Tradit. West. Med./Zhongguo Zhong xi yi jie he xue hui, Zhongguo Zhong yi yan jiu yuan zhu ban 2011, 31(11):1561-1564.
14. Liberati A., Altman D.G., Tetzlaff J., Mulrow C., Gotzsche P.C., Ioannidis J.P., Clarke M., Devereaux P.J., Kleijnen J., Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ (Clinical research ed) 2009, 339:b2700.
15. Ware J.E., Kosinski M., Keller S.D. SF-36 Physical and Mental Health Summary Scales: A User's Manual 1994, The Health Institute, New England Medical Center, Boston, MA.
16. Ware J.E., Gandek B., Kosinski M., Aaronson N.K., Apolone G., Brazier J., Bullinger M., Kaasa S., Leplege A., Prieto L., et al. The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J. Clin. Epidemiol. 1998, 51(11):1167-1170.
17. Li L., Wang H.M., Shen Y. Chinese SF-36 Health Survey: translation, cultural adaptation, validation, and normalisation. J. Epidemiol. Community Health 2003, 57(4):259-263.
18. Liang X.Y., Nie S.F., Qu K.Y., Peng X.X., Wei S., Zhu G.B., Wu L.J., Guo X.H., Xiao R., Ju L.R., et al. Evaluation of health-related quality of life among hypertensive patients in a rural area, PR China. J. Hum. Hypertens. 2006, 20(3):227-229.
19. Chien K.L., Huang P.J., Chen M.F., Chiang F.T., Lai L.P., Lee Y.T. Assessment of quality of life in a double-blind, randomized clinical trial of imidapril and captopril for hypertensive Chinese in Taiwan. Cardiovasc. Drugs Ther. 2002, 16(3):221-226. (Sponsored by the International Society of Cardiovascular Pharmacotherapy).
20. Higgins J.P.T., Green S. Cochrane Handbook For Systematic Reviews Of Interventions. Version 5.0.1 2012, The Cochrane Collaboration, Oxford, Updated March 2011. http://www.cochrane-handbook.org/.
21. Borenstein Michael, Hedges Larry V., Higgins Julian P.T., Rothstein Hannah R. Introduction to Meta-Analysis. Part 3: Fixed-effect Versus Random-Effect Models 2009, 61-102. John Wiley & Sons, West Sussex.
22. Laird N.M., Mosteller F., Borenstein M., Hedges L.V., Higgins J.P.T., Rothstein H.R. Some statistical methods for combining experimental results. Int. J. Technol. Assess. Health Care 1990, 6(1):5-30.
23. Begg C.B., Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994, 50(4):1088-1101.
24. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clinical research ed) 1997, 315(7109):629-634.
25. Yu X.D., Zhou W.Q., Cui L., et al. Effects of Luohuo capsules on dynamic blood pressure and life quality in the patient of hypertension. J. Tradit. Chin. Med. 2003, 44(12):912-915.
26. Liu Y. Clinical Study of Jiangya Capsules Combined With Nimodipine on Elderly Isolated Systolic Hypertension 2007, 17-56. China Academy of Chinese Medical Sciences, Beijing.
27. Mao H.Q. Clinical Study of Jiangya Capsules on Elderly Isolated Systolic Hypertension 2007, 13-63. China Academy of Chinese Medical Sciences, Beijing.
28. Fang X.M., Li F., He J.S., et al. Clinical observation of Tianma Gouteng decoction combined with captopril on the influence of the quality of life of hypertensive patients. Chin. J. Integr. Med. Cardio-Cerebrovasc. Dis. 2008, 2008(01):3-4.
29. Zhao W.M., Liu L.T., Li H., et al. Clinical observation of integrative Chinese and Western medicine therapy for senile simple systolic hypertension and improvement of their life quality. Beijing J. Tradit. Chin. Med. 2008, 12:915-918.
30. Guo P., Qian H.L., Gong C.Q., et al. The isolated systolic hypertension treated by blood circulation and induces diuresis method with Western Medicine combined: an report of 48 cases. Guangxi J. Tradit. Chin. Med. 2009, 2009(06):32-34.
31. Li H., Liu L.T., Zhao W.M., et al. Effect of traditional and integrative regimens on quality of life and early renal impairment in elderly patients with isolated systolic hypertension. Chin. J. Integr. Med. 2010, 16(3):216-221.
32. Liu A.P., Zhou J.C., Long H.P., et al. Effect of folium ginkgo tablets combined with betaloc tablets on improving quality of life of hypertensive patients. Cent. S. Pharm. 2010, 8(2):95-98.
33. Wei Y.Z. Treatment of hypertension with integrated traditional Chinese and Western Medicine and the improving effect on quality of life. J. Emerg. Tradit. Chin. Med. 2010, 2010(06):907-989.
34. Yu J., Xu F.Q. Clinical observation on Qingxuanjiangya decoction in treatment of essential hypertension with liver-kidney yin-deficiency and liver-yang hyperactivity syndrome. Chin. J. Integr. Med. Cardio-Cerebrovasc. Dis. 2010, 1:1-3.
35. Zhang J. The Clinical Study of Enrich the Kidney and Nourish the Liver on Elderly Isolated Systolic Hypertension 2011, 13-27. Guangzhou University of Traditional Chinese Medicine, Guangzhou.
36. Xiong X., Yang X., Liu W., Chu F., Wang P., Wang J. Trends in the treatment of hypertension from the perspective of traditional Chinese medicine. Evidence Based Complement. Altern. Med.: eCAM 2013, 2013:275279.
37. Wang J., Xiong X. Evidence-based Chinese medicine for hypertension. Evidence Based Complement. Altern. Med.: eCAM 2013, 2013:978398.
38. Wang J., Xiong X. Control strategy on hypertension in Chinese medicine. Evidence Based Complement. Altern. Med.: eCAM 2012, 2012:284847.
39. Xiong X., Yang X., Liu Y., Zhang Y., Wang P., Wang J. Chinese herbal formulas for treating hypertension in traditional Chinese medicine: perspective of modern science. Hypertens. Res. 2013, 36(7):570-579. (Official Journal of the Japanese Society of Hypertension).
40. Fujisawa T., Ogihara T. Quality of life and the treatment of hypertension in the elderly. Nihon Ronen Igakkai zasshi Jpn. J. Geriat. 2007, 44(4):452-455.
41. Ogunlana M.O., Adedokun B., Dairo M.D., Odunaiya N.A. Profile and predictor of health-related quality of life among hypertensive patients in south-western Nigeria. BMC Cardiovasc. Disord. 2009, 9:25.
42. Tang X.D., Bian L.Q., Gao R., et al. ation into the preparation of placebos used in Chinese medicinal clinical trial. Chin. J. Integr. Tradit. West. Med. 2009, 2009(07):656-658.
43. Schulz K.F., Altman D.G., Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. Zhong xi yi jie he xue bao 2010, 8(7):604-612. (Chinese version).
44. Schulz K.F., Altman D.G., Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ (Clinical research ed) 2010, 340:c332.